These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9701364

  • 21. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R, Carbone R, Reiss M, Lacy J.
    Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
    [Abstract] [Full Text] [Related]

  • 22. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM.
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced down-regulation of glucose transporting activities in mouse 3T3-L1 preadipocyte.
    Nagashima H, Matsumura F.
    J Environ Sci Health B; 2002 Jan; 37(1):1-14. PubMed ID: 11990355
    [Abstract] [Full Text] [Related]

  • 29. Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism.
    Jansen B, Wadl H, Inoue SA, Trülzsch B, Selzer E, Duchêne M, Eichler HG, Wolff K, Pehamberger H.
    Antisense Res Dev; 1995 Jan; 5(4):271-7. PubMed ID: 8746776
    [Abstract] [Full Text] [Related]

  • 30. Antisense c-myc inhibition of lymphoma growth.
    Wickstrom E.
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):225-8. PubMed ID: 9212915
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.
    Thallinger C, Wolschek MF, Maierhofer H, Skvara H, Pehamberger H, Monia BP, Jansen B, Wacheck V, Selzer E.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4185-91. PubMed ID: 15217956
    [Abstract] [Full Text] [Related]

  • 33. Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.
    Yu B, Mao Y, Bai LY, Herman SE, Wang X, Ramanunni A, Jin Y, Mo X, Cheney C, Chan KK, Jarjoura D, Marcucci G, Lee RJ, Byrd JC, Lee LJ, Muthusamy N.
    Blood; 2013 Jan 03; 121(1):136-47. PubMed ID: 23165478
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antisense and/or immunostimulatory oligonucleotide therapeutics.
    Agrawal S, Kandimalla ER.
    Curr Cancer Drug Targets; 2001 Nov 03; 1(3):197-209. PubMed ID: 12188879
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide.
    Putney SD, Brown J, Cucco C, Lee R, Skorski T, Leonetti C, Geiser T, Calabretta B, Zupi G, Zon G.
    Antisense Nucleic Acid Drug Dev; 1999 Oct 03; 9(5):451-8. PubMed ID: 10555152
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice.
    Bennett CF, Kornbrust D, Henry S, Stecker K, Howard R, Cooper S, Dutson S, Hall W, Jacoby HI.
    J Pharmacol Exp Ther; 1997 Feb 03; 280(2):988-1000. PubMed ID: 9023316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.